JPS53109948A - Pharmaceutical composition having improved hemostatic effect - Google Patents

Pharmaceutical composition having improved hemostatic effect

Info

Publication number
JPS53109948A
JPS53109948A JP2409477A JP2409477A JPS53109948A JP S53109948 A JPS53109948 A JP S53109948A JP 2409477 A JP2409477 A JP 2409477A JP 2409477 A JP2409477 A JP 2409477A JP S53109948 A JPS53109948 A JP S53109948A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
hemostatic effect
improved hemostatic
improved
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2409477A
Other languages
Japanese (ja)
Other versions
JPS6029361B2 (en
Inventor
Yasuhito Yamanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiraimatsu Shinyaku KK
Original Assignee
Shiraimatsu Shinyaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiraimatsu Shinyaku KK filed Critical Shiraimatsu Shinyaku KK
Priority to JP52024094A priority Critical patent/JPS6029361B2/en
Priority to AU33529/78A priority patent/AU517518B2/en
Priority to DE2808572A priority patent/DE2808572C2/en
Priority to GB8620/78A priority patent/GB1563490A/en
Priority to CH233778A priority patent/CH639558A5/en
Priority to FR7806187A priority patent/FR2382236A1/en
Priority to NL7802359A priority patent/NL7802359A/en
Publication of JPS53109948A publication Critical patent/JPS53109948A/en
Publication of JPS6029361B2 publication Critical patent/JPS6029361B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP52024094A 1977-03-04 1977-03-04 Pharmaceutical composition with enhanced hemostatic effect Expired JPS6029361B2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP52024094A JPS6029361B2 (en) 1977-03-04 1977-03-04 Pharmaceutical composition with enhanced hemostatic effect
AU33529/78A AU517518B2 (en) 1977-03-04 1978-02-22 Hemostatic composition with atleast two of phytonadione adrenochrome monosemicarbazone and ascorbic acid
DE2808572A DE2808572C2 (en) 1977-03-04 1978-02-28 Hemostatic agent
GB8620/78A GB1563490A (en) 1977-03-04 1978-03-03 Hemostatic formulation
CH233778A CH639558A5 (en) 1977-03-04 1978-03-03 Haemostatic preparation
FR7806187A FR2382236A1 (en) 1977-03-04 1978-03-03 HEMOSTATIC COMPOSITION CONTAINING AT LEAST TWO ELEMENTS CHOSEN FROM PHYTONADIONE, ADRENOCHROME MONOSEMICARBAZONE AND ASCORBIC ACID
NL7802359A NL7802359A (en) 1977-03-04 1978-03-03 BLOOD-STOPPING PREPARATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52024094A JPS6029361B2 (en) 1977-03-04 1977-03-04 Pharmaceutical composition with enhanced hemostatic effect

Publications (2)

Publication Number Publication Date
JPS53109948A true JPS53109948A (en) 1978-09-26
JPS6029361B2 JPS6029361B2 (en) 1985-07-10

Family

ID=12128780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52024094A Expired JPS6029361B2 (en) 1977-03-04 1977-03-04 Pharmaceutical composition with enhanced hemostatic effect

Country Status (7)

Country Link
JP (1) JPS6029361B2 (en)
AU (1) AU517518B2 (en)
CH (1) CH639558A5 (en)
DE (1) DE2808572C2 (en)
FR (1) FR2382236A1 (en)
GB (1) GB1563490A (en)
NL (1) NL7802359A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63167663U (en) * 1987-04-20 1988-11-01
EP0644754A4 (en) * 1990-12-06 1995-12-27 Leslie Binshyang Soong Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes.

Also Published As

Publication number Publication date
FR2382236B1 (en) 1981-07-24
DE2808572C2 (en) 1982-11-11
JPS6029361B2 (en) 1985-07-10
FR2382236A1 (en) 1978-09-29
AU3352978A (en) 1979-08-30
NL7802359A (en) 1978-09-06
AU517518B2 (en) 1981-08-06
CH639558A5 (en) 1983-11-30
GB1563490A (en) 1980-03-26
DE2808572A1 (en) 1978-09-07

Similar Documents

Publication Publication Date Title
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
IL56110A0 (en) Absorbabale hemostatic compositions
KE3525A (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
JPS5394038A (en) Pharmaceutical composition
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
ZA78671B (en) Pharmaceutical compositions
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
JPS53101520A (en) Pharmaceutical composition
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
ZA782736B (en) Pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
JPS53109948A (en) Pharmaceutical composition having improved hemostatic effect
JPS5480427A (en) Pharmaceutical composition having antiiviral property
JPS542338A (en) Pharmaceutical composition